NCT04989517 Study of Efficacy and Safety of Investigational Treatment in Patients With Hidradenitis Suppurativa Status COMPLETED Phase PHASE1
NCT04988308 A Study of Bermekimab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa Status TERMINATED Phase PHASE2
NCT04982432 Orismilast for the Treatment of Mild to Severe Hidradenitis Suppurativa Status UNKNOWN Phase PHASE2
NCT04979520 Molecular Characteristics of Brodalumab in Hidradenitis Suppurativa Status COMPLETED Phase EARLY_PHASE1
NCT04901195 A Study to Test the Long-term Treatment of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04876391 A Study Investigating Long-term Treatment With Spesolimab in People With a Skin Disease Called Hidradenitis Suppurativa Who Completed a Previous Clinical Trial Status COMPLETED Phase PHASE2
NCT04856930 A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With Hidradenitis Suppurativa Status COMPLETED Phase PHASE2
NCT04772885 A Single and Multiple Ascending Dose Trial of KT-474 in Healthy Adult Volunteers and Patients With Atopic Dermatitis (AD) or Hidradenitis Suppurativa (HS) Status COMPLETED Phase PHASE1
NCT04762277 A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa Status COMPLETED Phase PHASE2
NCT04649502 Metformin for the Treatment of Hidradenitis Suppurativa (HS) Status COMPLETED Phase PHASE3
NCT04600375 Evaluating the Effect of a Written Action Plan on Comfort and Understanding of Hidradenitis Suppurativa Status COMPLETED Phase NA
NCT04582669 Optimizing Intralesional Triamcinolone Dosing for Hidradenitis Suppurativa Status TERMINATED Phase PHASE4
NCT04541550 Allogeneic Micronized Amniotic Membrane Product for the Treatment of Hidradenitis Suppurativa Status WITHDRAWN Phase PHASE1
NCT04508374 Intralesional Diode Laser Treatment of Fistulas in Hidradenitis Suppurativa Status UNKNOWN Phase NA
NCT04493502 A Study of LY3041658 in Adults With Hidradenitis Suppurativa Status COMPLETED Phase PHASE2
NCT04476043 To Assess the Efficacy and Safety of INCB054707 in Participants With Hidradenitis Suppurativa Status COMPLETED Phase PHASE2